Researchers are testing whether drugs designed to quiet the immune system can lift severe depression that resists ...

Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...

Well, good morning, everybody, and thank you once again for joining us for the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

“For a patient with severe MES 3 disease, speed of onset is a priority, so it may be reasonable to prioritize use of upadacitinib or infliximab given their incremental efficacy with increasing ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

The Food and Drug Administration Monday unveiled the details of a new policy designed to make it easier and quicker for patients with very rare diseases to get cutting-edge treatments. The new ...

A new analysis dives into why Europe’s eye clinics lag on biosimilars and how education, guidance, and smarter tenders could ...